HomeCompareCBLLX vs JNJ

CBLLX vs JNJ: Dividend Comparison 2026

CBLLX yields 0.88% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBLLX wins by $906.00 in total portfolio value
10 years
CBLLX
CBLLX
● Live price
0.88%
Share price
$11.42
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$93.67
Full CBLLX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CBLLX vs JNJ

📍 CBLLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBLLXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBLLX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBLLX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBLLX
Annual income on $10K today (after 15% tax)
$75.18/yr
After 10yr DRIP, annual income (after tax)
$79.62/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $623.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBLLX + JNJ for your $10,000?

CBLLX: 50%JNJ: 50%
100% JNJ50/50100% CBLLX
Portfolio after 10yr
$20.5K
Annual income
$460.72/yr
Blended yield
2.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CBLLX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBLLX buys
0
JNJ buys
0
No recent congressional trades found for CBLLX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBLLXJNJ
Forward yield0.88%3.36%
Annual dividend / share$0.10$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.9K$20.0K
Annual income after 10y$93.67$827.78
Total dividends collected$913.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CBLLX vs JNJ ($10,000, DRIP)

YearCBLLX PortfolioCBLLX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,788$88.44$10,676$355.77+$112.00CBLLX
2$11,633$89.17$11,407$389.39+$226.00CBLLX
3$12,537$89.86$12,198$426.53+$339.00CBLLX
4$13,505$90.51$13,056$467.62+$449.00CBLLX
5$14,542$91.12$13,987$513.12+$555.00CBLLX
6$15,651$91.70$14,998$563.56+$653.00CBLLX
7$16,839$92.24$16,098$619.52+$741.00CBLLX
8$18,110$92.74$17,295$681.69+$815.00CBLLX
9$19,471$93.22$18,599$750.82+$872.00CBLLX
10$20,928$93.67$20,022$827.78+$906.00CBLLX

CBLLX vs JNJ: Complete Analysis 2026

CBLLXStock

The fund invests at least 80% of its net assets in equity securities of large-capitalization companies. It is a feeder fund that invests substantially all of its assets in the C&B Large Cap Value Portfolio, a master portfolio with a substantially identical investment objective and substantially similar investment strategies. The fund invests principally in equity securities of large-capitalization companies, which is defined as companies with market capitalizations within the range of the Russell 1000® Index at the time of purchase.

Full CBLLX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CBLLX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBLLX vs SCHDCBLLX vs JEPICBLLX vs OCBLLX vs KOCBLLX vs MAINCBLLX vs ABBVCBLLX vs MRKCBLLX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.